Anthropic 的新战略：既向生物科技公司出售工具，又自行研发药物
anthropic 发布了针对科学的 'claude science' 工作台，并宣布计划自行研发治疗被忽视疾病的药物，这标志着它从软件供应商向制药领域直接参与者的转型。
anthropic introduced claude science, an integrated workbench for scientists, and declared its intent to develop proprietary drugs, focusing on neglected diseases. while the firm lists major biotech clients, this move pits it against partners like pfizer and merck, creating a complex vendor-customer dynamic. anthropic provided few details on clinical trials or manufacturing, but this escalation mirrors trends by google's isomorphic labs. the strategy proves that frontier labs are moving beyond text generation into high-stakes, real-world biology applications where failures can cost billions.